Drug Approval | June 27, 2025
Biocon Biologics receives Health Canada approval for Yesafili
The approval is based on a comprehensive package of analytical, nonclinical, and clinical data
The approval is based on a comprehensive package of analytical, nonclinical, and clinical data
Star Health Insurance is modernising its claims ecosystem to be future-ready
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
Changhua site meets international regulatory standards for global medical applications
This collaboration ensures that patients receive comprehensive care, including emotional and psychological support throughout their fertility journey
The CR Bio unit represents a non-core legacy asset with limited strategic alignment to our core CDMO operations
The transaction is expected to close in Q2 FY 2026
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
The inspection concluded successfully, with the facility found to be in compliance with the required regulations
The collaboration furthers AstraZeneca’s presence in China following the $2.5bn investment in Beijing
Subscribe To Our Newsletter & Stay Updated
